Organization
Almazov National Medical Research Centre
3 abstracts
Abstract
Ponatinib (PON) in patients (pts) with chronic-phase chronic myeloid leukemia (CP-CML) and the T315I mutation (mut): 4-year results from OPTIC.Org: Versiti Blood Research Institute, Division of Hematology and Oncology, Medical College of Wisconsin, Imperial College London, Royal North Shore Hospital, Singapore General Hospital, Duke-NUS Medical School,
Abstract
ANALYSIS OF 38 CYTOKINES PROFILE IN CHILDREN WITH SYSTEMIC LUPUS ERYTHEMATOSUSOrg: Saint-Petersburg State Pediatric Medical University, Saint-Petersburg, Russian Federation, City Hospital №40, Almazov National Medical Research Centre, N.N.Petrov Institute of Oncology,
Abstract
ANALYSIS OF INTERFERON TYPE I SIGNATURE IN JUVENILE DERMATOMYOSITISOrg: Saint-Petersburg State Pediatric Medical University, Saint-Petersburg, Russian Federation, City Hospital №40, N.N.Petrov Institute of Oncology, Almazov National Medical Research Centre,